In HD, immunoreactivity of NPY is augmented not only in the basal ganglia but also in other brain areas such as the cortex and the subventricular zone [92,93,94], indicating an increase in the number of NPY-expressing cells, likely in an attempt to compensate for the malfunction of the affected neuronal cell subtypes. This evidence concerns the gene NPY and Huntington disease.